These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8385430)

  • 1. Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses.
    Friedman BS; Bel EH; Buntinx A; Tanaka W; Han YH; Shingo S; Spector R; Sterk P
    Am Rev Respir Dis; 1993 Apr; 147(4):839-44. PubMed ID: 8385430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.
    Hui KP; Taylor IK; Taylor GW; Rubin P; Kesterson J; Barnes NC; Barnes PJ
    Thorax; 1991 Mar; 46(3):184-9. PubMed ID: 1851340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiasthmatic effects of a leukotriene biosynthesis inhibitor (MK-0591) in allergic dogs.
    Becker AB; Black C; Lilley MK; Bajwa K; Ford-Hutchinson AW; Simons FE; Tagari P
    J Appl Physiol (1985); 1995 Feb; 78(2):615-22. PubMed ID: 7759431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion.
    O'Shaughnessy KM; Wellings R; Gillies B; Fuller RW
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1472-6. PubMed ID: 8389108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
    Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.
    Nasser SM; Bell GS; Hawksworth RJ; Spruce KE; MacMillan R; Williams AJ; Lee TH; Arm JP
    Thorax; 1994 Aug; 49(8):743-8. PubMed ID: 8091317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects.
    Bancalari L; Conti I; Giannessi D; Lazzerini G; Dente FL; De Caterina R; Paggiaro PL
    Allergy; 1999 Dec; 54(12):1278-85. PubMed ID: 10688431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin.
    Sladek K; Dworski R; Fitzgerald GA; Buitkus KL; Block FJ; Marney SR; Sheller JR
    Am Rev Respir Dis; 1990 Jun; 141(6):1441-5. PubMed ID: 2161626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma.
    Barchuk W; Lambert J; Fuhr R; Jiang JZ; Bertelsen K; Fourie A; Liu X; Silkoff PE; Barnathan ES; Thurmond R
    Pulm Pharmacol Ther; 2014 Oct; 29(1):15-23. PubMed ID: 25018015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
    Twentyman OP; Finnerty JP; Holgate ST
    Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
    Evans DJ; Barnes PJ; Spaethe SM; van Alstyne EL; Mitchell MI; O'Connor BJ
    Thorax; 1996 Dec; 51(12):1178-84. PubMed ID: 8994512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways.
    O'Hickey SP; Hawksworth RJ; Fong CY; Arm JP; Spur BW; Lee TH
    Am Rev Respir Dis; 1991 Nov; 144(5):1053-7. PubMed ID: 1659268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
    Diamant Z; Van der Veen H; Kuijpers EA; Bakker PF; Sterk PJ
    Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
    Dahlén B; Kumlin M; Ihre E; Zetterström O; Dahlén SE
    Thorax; 1997 Apr; 52(4):342-7. PubMed ID: 9196517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
    Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
    Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.
    Roquet A; Dahlén B; Kumlin M; Ihre E; Anstrén G; Binks S; Dahlén SE
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1856-63. PubMed ID: 9196086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors.
    Tagari P; Brideau C; Chan C; Frenette R; Black C; Ford-Hutchinson A
    Agents Actions; 1993 Sep; 40(1-2):62-71. PubMed ID: 8147271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.